Accessibility Menu
 
Fisher & Paykel Healthcare logo

Fisher & Paykel Healthcare

(OTC) FSPKF

Current Price$22.31
Market Cap$13.10B
Since IPO (2003)+238%
5 Year+19%
1 Year+30%
1 Month-5%

Fisher & Paykel Healthcare Financials at a Glance

Market Cap

$13.10B

Revenue (TTM)

$4.26B

Net Income (TTM)

$767.11M

EPS (TTM)

$0.43

P/E Ratio

51.08

Dividend

$0.35

Beta (Volatility)

0.29 (Low)

Price

$22.31

Volume

252

Open

$22.31

Previous Close

$22.31

Daily Range

$22.31 - $22.31

52-Week Range

$16.31 - $25.69

FSPKF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fisher & Paykel Healthcare

Industry

Healthcare Equipment and Supplies

Employees

7,535

CEO

Lewis George Gradon

Headquarters

Auckland, 2013, NZ

FSPKF Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

27%

Net Income Margin

20%

Return on Equity

22%

Return on Capital

26%

Return on Assets

16%

Earnings Yield

1.96%

Dividend Yield

0.02%

Payout Ratio

57.35%

Stock Overview

Market Cap

$13.10B

Shares Outstanding

587.28M

Volume

252

Short Interest

0.00%

Avg. Volume

1.17K

Financials (TTM)

Gross Profit

$530.20M

Operating Income

$371.00M

EBITDA

$654.30M

Operating Cash Flow

$548.60M

Capital Expenditure

$103.00M

Free Cash Flow

$445.60M

Cash & ST Invst.

$264.50M

Total Debt

$153.30M

Fisher & Paykel Healthcare Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.09B

+33.9%

Gross Profit

$692.58M

+39.0%

Gross Margin

63.42%

N/A

Market Cap

$13.10B

N/A

Market Cap/Employee

$1.88M

N/A

Employees

6,978

N/A

Net Income

$211.41M

+97.0%

EBITDA

$361.47M

+77.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$150.66M

+159.6%

Accounts Receivable

$328.92M

+25.6%

Inventory

$334.38M

-7.1%

Long Term Debt

$62.13M

-77.8%

Short Term Debt

$84.96M

+109.8%

Return on Assets

15.97%

N/A

Return on Invested Capital

26.29%

N/A

Free Cash Flow

$192.35M

+261.6%

Operating Cash Flow

$243.96M

+55.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALBBYAlibaba Health Information Technology Limited
$15.50+0.00%
ERFSFEurofins Scientific SE
$68.17-5.47%
SSSGYSartorius AG
$42.02+0.00%
CHJTFCSPC Pharmaceutical Group Limited
$1.02-12.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About FSPKF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.